J.R. Herlihy
Analyst · KBW. Your line is now active.
Sure. So thanks for the question Jr. I'll start out. And then Mark and Larry obviously supplement as you see fit. So the 3.8 times includes all of the non QM securitizations that we consolidate for gap. So that's a total leverage statistic, but recourse test equity which we talk about that's the, that's the ratio we focus on, cause it excludes non-recourse financing, which is largely the non-QM securitizations that measure did increase from 2.3 to one to 2.6 to one quarter of a quarter. And 2.6 times is higher than it's been kind of post COVID, but not as high as it was pre COVID. We gave the statistic that unencumbered assets about $600 million and plus cash of another two and a quarter. So we, we still had, that's one of the ways that we measure, dry powder. Larry mentioned that we closed on the senior notes on March 31st. So that was 210 million of those income -- of the dry powders as we think about it. So I think it, the, the answer to this question is usually it depends on the opportunities, having that many unencumbered assets and cash that is above the balance that we typically carry implies that we have more borrowing capacity. On the other hand, we did do a securitization that closed last week. And so that takes recourse financing off our balance sheet, but we've also, continued to take advantage of investment opportunities. So there are different moving pieces. But I think in short we still have room to take leverage up further. Does unencumbered assets of about $600 million, if you say, let's just say $400 million is readily financable at attractive rates, and we leverage that one to one or thereabouts that would raise another $400 million plus another say $50 million of our cash. Cash is higher relative to NAV than it typically is that that math would get us to the high twos before accounting for securitization. So we don’t typically give leverage targets, but those numbers might give you a sense of how much borrowing capacity we have remaining if we choose to use it. Yeah. And just to reemphasize what J. R. said when you think about where our leverage could go, I wouldn’t focus on that recourse number because the non QM securitizations do blow up the balance sheet. And, but the amount of, they don’t blow up the balance sheet with incremental risk, as far as that financing being pulled, right. That’s locked in long term financing. So when we do a $350 million securitization and well, in the old days, we would retain, 20 million worth of assets, usually mostly IO, non-QM, and some subordinate tranches as well.